Last updated: 2026-10-13 12:35:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Celularity Inc. (CELU) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.49, with a market capitalisation of $50.62M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.56 to $2.55. This page covers its latest market performance, valuation, price trends and company information.
$50.62M | |
$1.48 | |
$134.00 | |
$0.56 | |
$1.47 | |
994.00 | |
3.95M | |
-- | |
$2.55 | |
$0.56 | |
-- | |
-- |
Celularity Inc. (CELU) is trading at $1.49 in pre-market trading as of 2026-10-13 11:37:00, up 1.09% ($0.02) from the previous close of $1.47
Pre-market trading shows how investors are pricing CELU before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Celularity Inc. (CELU) moved from $1.60 to $1.49, representing a decline of 7.13% ($0.11).
The stock traded between $1.36 and $1.80 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 147.79 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 46.5%
CELU is currently trading at $1.49, placing it 46.5% of the way from its 52-week low of $0.56 to its 52-week high of $2.55. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 115 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Celularity Inc. (CELU) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.